keyword
https://read.qxmd.com/read/34800827/budget-impact-analysis-of-hypertonic-saline-inhalations-for-infant-bronchiolitis-the-colombian-national-health-system-perspective
#41
JOURNAL ARTICLE
Jefferson Antonio Buendía, Diana Guerrero Patiño
OBJECTIVES: Nebulized 3% hypertonic solution (HS) is associated with lower total cost and higher quality-adjusted life-years. Nevertheless, the expected budget impact of this drug had not been explicitly estimated. The aim of this study was to evaluate the budget impact of 3% HS in the treatment of acute bronchiolitis in Colombia. METHODS: A budget impact analysis was performed to evaluate the potential financial impact of the use of 3% HS. The analysis considered a 4-year time horizon and a Colombian national health system perspective...
November 17, 2021: Value in Health Regional Issues
https://read.qxmd.com/read/34779191/aspects-of-the-modern-management-of-bronchiectasis
#42
JOURNAL ARTICLE
John Kolbe
While bronchiectasis is an old condition, it is only in the last decade that there have been major strides in our understanding of this disease and its treatment. Recent evidence has shown that the "vicious cycle" hypothesis remains valid. This, and the concept of "treatable traits," provide useful frameworks on which to base the management of this condition. In all recently diagnosed patients, a search should be undertaken for specific etiologies. A number of factors, including chronic infection by Pseudomonas aeruginosa, have been shown to be associated with increased morbidity and mortality...
January 28, 2022: Polish Archives of Internal Medicine
https://read.qxmd.com/read/34728474/enhanced-airway-sensory-nerve-reactivity-in-non-eosinophilic-asthma
#43
JOURNAL ARTICLE
Hajar Ali, Collin Brooks, Julian Crane, Richard Beasley, Stephen Holgate, Peter Gibson, Philip Pattemore, Yu-Chieh Tzeng, Thorsten Stanley, Neil Pearce, Jeroen Douwes
BACKGROUND: Neural mechanisms may play an important role in non-eosinophilic asthma (NEA). This study compared airway sensory nerve reactivity, using capsaicin challenge, in eosinophilic asthma (EA) and NEA and non-asthmatics. METHODS: Thirty-eight asthmatics and 19 non-asthmatics (aged 14-21 years) underwent combined hypertonic saline challenge/sputum induction, fractional exhaled nitric oxide, atopy and spirometry tests, followed by capsaicin challenge. EA and NEA were defined using a sputum eosinophil cut-point of 2...
November 2021: BMJ Open Respiratory Research
https://read.qxmd.com/read/34726628/salt-therapy-as-a-complementary-method-for-the-treatment-of-respiratory-tract-diseases-with-a-focus-on-mold-related-illness
#44
JOURNAL ARTICLE
Anita A Wasik, Tamara Tuuminen
Salt therapy has been used for millennia, but modern salt therapy can be traced to the salt mines and caves in Europe and Russia from the early 19th century. Today, breathing in the microclimate of caves with their stable air temperature and moderate to high humidity in the presence of sodium, potassium, magnesium and calcium and the absence of airborne pollutants and pollen is called speleotherapy. The inhalation of natural pure sodium chloride (NaCl) in a controlled environment (air temperature 18° to 24°C and relative humidity 40% to 60%) is called halotherapy...
October 2021: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/34697091/inhaled-gene-therapy-of-preclinical-muco-obstructive-lung-diseases-by-nanoparticles-capable-of-breaching-the-airway-mucus-barrier
#45
JOURNAL ARTICLE
Namho Kim, Gijung Kwak, Jason Rodriguez, Alessandra Livraghi-Butrico, Xinyuan Zuo, Valentina Simon, Eric Han, Siddharth Kaup Shenoy, Nikhil Pandey, Marina Mazur, Susan E Birket, Anthony Kim, Steven M Rowe, Richard Boucher, Justin Hanes, Jung Soo Suk
INTRODUCTION: Inhaled gene therapy of muco-obstructive lung diseases requires a strategy to achieve therapeutically relevant gene transfer to airway epithelium covered by particularly dehydrated and condensed mucus gel layer. Here, we introduce a synthetic DNA-loaded mucus-penetrating particle (DNA-MPP) capable of providing safe, widespread and robust transgene expression in in vivo and in vitro models of muco-obstructive lung diseases. METHODS: We investigated the ability of DNA-MPP to mediate reporter and/or therapeutic transgene expression in lung airways of a transgenic mouse model of muco-obstructive lung diseases (ie, Scnn1b -Tg) and in air-liquid interface cultures of primary human bronchial epithelial cells harvested from an individual with cystic fibrosis...
October 25, 2021: Thorax
https://read.qxmd.com/read/34625378/safety-of-airway-clearance-combined-with-bronchodilator-and-hypertonic-saline-in-non-hospitalized-infants-with-acute-bronchiolitis
#46
JOURNAL ARTICLE
Vanesa González Bellido, Verónica Veláz Baza, Mª Del Carmen Jimeno Esteo, Rubén García Carballo, Alicia Colombo, Juan Nicolás Cuenca Zaldívar, Márcio Vinícius Fagundes Donadio
BACKGROUND: Acute viral bronchiolitis (AVB) is associated with significant morbidity and no study has addressed the safety of airway clearance techniques (ACT) for non-hospitalized infants. This study aimed to evaluate the safety of the use of ACT combined with bronchodilator and hypertonic saline in non-hospitalized children with the first episode of AVB. METHODS: A quasi-experimental study of infants aged 2-12 months, with a clinical diagnosis of AVB (mild to moderate), was performed...
November 2021: Archives de Pédiatrie: Organe Officiel de la Sociéte Française de Pédiatrie
https://read.qxmd.com/read/34576767/current-and-emerging-therapies-to-combat-cystic-fibrosis-lung-infections
#47
REVIEW
Jim Manos
The ultimate aim of any antimicrobial treatment is a better infection outcome for the patient. Here, we review the current state of treatment for bacterial infections in cystic fibrosis (CF) lung while also investigating potential new treatments being developed to see how they may change the dynamics of antimicrobial therapy. Treatment with antibiotics coupled with regular physical therapy has been shown to reduce exacerbations and may eradicate some strains. Therapies such as hypertonic saline and inhaled PulmozymeTM (DNase-I) improve mucus clearance, while modifier drugs, singly and more successfully in combination, re-open certain mutant forms of the cystic fibrosis transmembrane conductance regulator (CFTR) to enable ion passage...
September 3, 2021: Microorganisms
https://read.qxmd.com/read/34572697/aerosolized-hypertonic-saline-hinders-biofilm-formation-to-enhance-antibiotic-susceptibility-of-multidrug-resistant-acinetobacter-baumannii
#48
JOURNAL ARTICLE
Hui-Ling Lin, Chen-En Chiang, Mei-Chun Lin, Mei-Lan Kau, Yun-Tzu Lin, Chi-Shuo Chen
Limited therapeutic options are available for multidrug-resistant Acinetobacter baumannii (MDR-AB), and the development of effective treatments is urgently needed. The efficacy of four aerosolized antibiotics (gentamicin, amikacin, imipenem, and meropenem) on three different MDR-AB strains was evaluated using hypertonic saline (HS, 7 g/100 mL) as the aerosol carrier. HS aerosol effectively hindered biofilm formation by specific MDR-AB strains. It could also interrupt the swarming dynamics of MDR-AB and the production of extracellular polymeric substances, which are essential for biofilm progression...
September 15, 2021: Antibiotics
https://read.qxmd.com/read/34499820/bronchodilator-response-to-albuterol-nebulized-with-hypertonic-saline-in-asthmatic-children
#49
RANDOMIZED CONTROLLED TRIAL
Alejandro Teper, Carlos Kofman, Jessica Alchundia Moreira, Teresa Köhler, Facundo García Bournissen
INTRODUCTION: Asthma is distinguished by bronchial obstruction reversible by bronchodilators. The first-line treatment for asthmatic exacerbations is the use of inhaled beta-agonists, by pressurized metered-dose inhalers or nebulized with normal saline solution (NSS). There are no reports of nebulized beta agonists' efficacy in asthmatic children when administered with hypertonic saline solution (HSS). OBJECTIVE: To evaluate bronchodilator responses (BDR) to albuterol nebulized with 3%-HSS in asthmatic children, compared to albuterol nebulized with NSS...
December 2021: Pediatric Pulmonology
https://read.qxmd.com/read/34497037/treatment-patterns-in-people-with-cystic-fibrosis-have-they-changed-since-the-introduction-of-ivacaftor
#50
JOURNAL ARTICLE
Emily Granger, Gwyneth Davies, Ruth H Keogh
BACKGROUND: In late 2012, ivacaftor became available in the UK for people with cystic fibrosis (CF) aged 6 years and over with a G551D mutation. Long-term changes in treatment patterns have not previously been reported. We investigated long-term treatment patterns in people with CF with a G551D mutation who took ivacaftor and compared these with non-ivacaftor-treated cohorts using the UK Cystic Fibrosis Registry. METHODS: Using 2007-2018 data we compared treatment patterns between four cohorts: 1: ivacaftor-treated; 2: ivacaftor era (2013-2018), ineligible genotype (no G551D mutation); 3: pre-ivacaftor era (2007-2012), eligible genotype (G551D mutation); 4: pre-ivacaftor era, ineligible genotype...
September 5, 2021: Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society
https://read.qxmd.com/read/34460083/reversal-of-sars-cov2-induced-hypoxia-by-nebulized-sodium-ibuprofenate-in-a-compassionate-use-program
#51
JOURNAL ARTICLE
Oscar Salva, Pablo A Doreski, Celia S Giler, Dario C Quinodoz, Lucia G Guzmán, Sonia E Muñoz, Mariana N Carrillo, Daniela J Porta, Germán Ambasch, Esteban Coscia, Jorge L Tambini Diaz, Germán D Bueno, Jorge O Fandi, Miriam A Maldonado, Leandro E Peña Chiappero, Fernando Fournier, Hernán A Pérez, Mauro A Quiroga, Javier A Sala Mercado, Carlos Martínez Picco, Marcelo Alejandro Beltrán, Luis A Argañarás, Nicolás Martínez Ríos, Galia I Kalayan, Dante M Beltramo, Néstor H García
INTRODUCTION: Sodium ibuprofenate in hypertonic saline (NaIHS) administered directly to the lungs by nebulization and inhalation has antibacterial and anti-inflammatory effects, with the potential to deliver these benefits to hypoxic patients. We describe a compassionate use program that offered this therapy to hospitalized COVID-19 patients. METHODS: NaIHS (50 mg ibuprofen, tid) was provided in addition to standard of care (SOC) to hospitalized COVID-19 patients until oxygen saturation levels of > 94% were achieved on ambient air...
August 30, 2021: Infectious Diseases and Therapy
https://read.qxmd.com/read/34435248/induced-sputum-abnormalities-in-gas-station-attendants
#52
JOURNAL ARTICLE
Tiago Henrique Garcia da Silva, Ada Clarice Gastaldi, Marcel Koenigkam Santos, Bruno Spinosa de Martinis, José Baddini-Martinez
PURPOSE: To investigate inflammatory changes in the induced sputum (IS) of gas station attendants (GSAs) at risk of exposure to fuel vapors through inhalation and susceptible to respiratory complaints and impaired lung function. METHODS: Hypertonic saline-IS was collected from 52 GSAs who had never smoked (42 men, age = 35.9 ± 8.9 years) and had no known comorbidities. A group of 22 non-smokers (11 men, age = 30.5 ± 5.1 years) selected from the University staff served as control...
August 25, 2021: International Archives of Occupational and Environmental Health
https://read.qxmd.com/read/34383222/effectiveness-of-inhaled-hypertonic-saline-application-for-sputum-induction-to-improve-mycobacterium-tuberculosis-identification-in-patients-with-pulmonary-tuberculosis
#53
JOURNAL ARTICLE
Dmytro Butov, Yurii Feshchenko, Valeriy Myasoedov, Mykhailo Kuzhko, Mykola Gumeniuk, Galyna Gumeniuk, Anton Tkachenko, Nekrasova Nataliya, Olena Borysova, Tetiana Butova
BACKGROUND: This study assessed the effectiveness and diagnostic significance of hypertonic saline sputum induction for improving Mycobacterium tuberculosis (MTB) detection. METHODS: A prospective, randomized, open, two-arm, comparative study on MTB identification effectiveness when using inhaled sodium chloride hypertonic solution was performed in patients diagnosed with pulmonary tuberculosis (TB). Patients were randomly assigned into two groups: group 1 (inhalation group) included patients who inhaled a 7% sodium chloride solution upon admission to the hospital, and group 2 (control group) coughed up their sputum as usual...
August 12, 2021: Wiener Medizinische Wochenschrift
https://read.qxmd.com/read/34362426/hypertonic-saline-in-people-with-cystic-fibrosis-review-of-comparative-studies-and-clinical-practice
#54
JOURNAL ARTICLE
Vito Terlizzi, Eleonora Masi, Michela Francalanci, Giovanni Taccetti, Diletta Innocenti
Cystic fibrosis (CF) is a multisystem disorder, caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. These cause a reduced secretion of chloride, a marked absorption of sodium and, therefore, of water, through the epithelium, resulting in the formation of thickened secretions in organs such as lung or pancreas. These viscous secretions lead to airway obstruction, chronic infection and inflammation resulting in progressive lung damage, bronchiectasis and eventual respiratory failure...
August 6, 2021: Italian Journal of Pediatrics
https://read.qxmd.com/read/34322960/immediate-effect-of-inhalation-therapy-combined-with-oscillatory-positive-expiratory-pressure-on-the-respiratory-system-of-children-with-cystic-fibrosis
#55
JOURNAL ARTICLE
Renata Maba Gonçalves Wamosy, Tayná Castilho, Ana Carolina da Silva Almeida, Maíra Seabra de Assumpção, Norberto Ludwig Neto, Camila Isabel Santos Schivinski
INTRODUCTION: It is recommended the association of inhalation therapies and physiotherapy on the management of cystic fibrosis (CF); however, it is still necessary to understand the effect on respiratory mechanics of these therapies combined. This study aimed to evaluate the immediate effect of inhalation with Dornase-Alfa (DNase) and hypertonic saline solution (HSS), as well as the impact of these inhalation therapies associated with an oral high-frequency oscillation (OHFO) physiotherapy device, on the respiratory mechanics of children and adolescents with CF...
October 2021: International Journal of Clinical Practice
https://read.qxmd.com/read/34109248/acute-and-durable-effect-of-inhaled-hypertonic-saline-on-mucociliary-clearance-in-adult-asthma
#56
JOURNAL ARTICLE
William D Bennett, Allison Burbank, Martha Almond, Jihong Wu, Agathe Ceppe, Michelle Hernandez, Richard C Boucher, David B Peden
BACKGROUND: Impaired mucus clearance and airway mucus plugging have been shown to occur in moderate-severe asthma, especially during acute exacerbations. In cystic fibrosis, where airway mucus is dehydrated, it has been shown that inhaled hypertonic saline (HS) produces both acute and sustained enhancement of mucociliary clearance (MCC). The current study was designed to assess the acute and sustained effect of inhaled 7% HS on MCC in adult asthma. METHODS: Well-controlled, moderate-severe female asthmatic patients (n=8) were screened with a single test dose of albuterol (four puffs by metered-dose inhaler) followed by HS (7% sodium chloride, 4 mL using PARI LC Star nebuliser)...
April 2021: ERJ Open Research
https://read.qxmd.com/read/33975926/lung-function-in-children-with-cystic-fibrosis-in-the-usa-and-uk-a-comparative-longitudinal-analysis-of-national-registry-data
#57
JOURNAL ARTICLE
Daniela K Schlüter, Josh S Ostrenga, Siobhán B Carr, Aliza K Fink, Albert Faro, Rhonda D Szczesniak, Ruth H Keogh, Susan C Charman, Bruce C Marshall, Christopher H Goss, David Taylor-Robinson
RATIONALE: A previous analysis found significantly higher lung function in the US paediatric cystic fibrosis (CF) population compared with the UK with this difference apparently decreasing in adolescence and adulthood. However, the cross-sectional nature of the study makes it hard to interpret these results. OBJECTIVES: To compare longitudinal trajectories of lung function in children with CF between the USA and UK and to explore reasons for any differences. METHODS: We used mixed effects regression analysis to model lung function trajectories in the study populations...
May 11, 2021: Thorax
https://read.qxmd.com/read/33809583/considerations-for-and-mechanisms-of-adjunct-therapy-in-copd
#58
REVIEW
Rachana Mandru, Christine Y Zhou, Rachel Pauley, Robert M Burkes
Inhaled bronchodilators and corticosteroids, when indicated, form the backbone of COPD therapy. However, over the last decade there has been an emergence of adjunct therapies in oral or inhaled form that are now part of the therapeutic approach to COPD. While these therapies have shown to be beneficial when used in the appropriate instances, there are particular considerations that need to be minded when using these therapies. This review article discussed the mechanism of roflumilast, macrolide antibiotics, other chronic antibiotic regimens, vitamin D supplementation, oral corticosteroids, n-acetylcysteine, and nebulized hypertonic saline, the clinical data behind each of these therapies, adverse events associated with therapy, and the expert recommendations for their utilization...
March 16, 2021: Journal of Clinical Medicine
https://read.qxmd.com/read/33614774/characterisation-of-cough-evoked-by-inhaled-treprostinil-and-treprostinil-palmitil
#59
JOURNAL ARTICLE
Richard W Chapman, Michel R Corboz, Carlos Fernandez, Eugene Sullivan, Andy Stautberg, Adam J Plaunt, Donna M Konicek, Vladimir Malinin, Zhili Li, David Cipolla, Walter Perkins
Cough is induced by inhaled prostacyclin analogues including treprostinil (TRE), and, at higher doses, treprostinil palmitil (TP), a prodrug of TRE. In this report, we have investigated mechanisms involved in TRE- and TP-induced cough, using a dry powder formulation of TP (TPIP) to supplement previous data obtained with an aqueous suspension formulation of TP (TPIS). Experiments in guinea pigs and rats investigated the prostanoid receptor subtype producing cough and whether it involved activation of sensory nerves in the airways and vasculature...
January 2021: ERJ Open Research
https://read.qxmd.com/read/33295693/effectiveness-of-hypertonic-saline-nebulization-in-airway-clearance-in-children-with-non-cystic-fibrosis-bronchiectasis-a-randomized-control-trial
#60
RANDOMIZED CONTROLLED TRIAL
Kodippilikande W D A Anuradha, Paththini K Ganganath Gunathilaka, Vithanage P Wickramasinghe
INTRODUCTION: Failure to expectorate mucus resulting in progressive airway damage is the hallmark of bronchiectasis. Therefore effective airway clearance techniques (ACT) is the key step in its management. The aim of this study was to evaluate the efficacy of 3% hypertonic saline (HS) pre-medication in ACT in children with non cystic fibrosis (non-CF) bronchiectasis. METHODS: In this randomized crossover control trial five to 15 year old children, diagnosed with non-CF bronchiectasis were randomized either to receive 200 µg of inhaled salbutamol followed by HS nebulization (test) or only 200 µg of inhaled salbutamol, before chest physiotherapy which is the conventional ACT (controls) for 8 weeks...
February 2021: Pediatric Pulmonology
keyword
keyword
103220
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.